Pairing Nutrition with Regenerative Therapy
Tue, 2/1 4:49PM • 1:35:59
SUMMARY KEYWORDS
patients, mechanism, issues, tissue, activity, inflammation, body, pretty, put, stem cells, substance, participate, epigenetic, genetics, lifestyle, good, interesting, integrated, intervention, joint
Bill Clearfield 07:37
Our speaker tonight, Dr. Brad Watts is quite a prolific speaker. I don’t know how you could do it all. And sounds so you know, cogent and everything. I mean, you know, it takes me hours and you know, days and weeks to put together an hour thing. You’re doing it every every week. I mean you really you know really killing it.
08:24
Wow. Thank you. I’m glad you’re participating in that. That’s fun.
Bill Clearfield 08:28
So, yes, and I we I’ve shared it with the group and wouldn’t welcome to you know, share your whatever whatever it is that you’re you know, you want to promote. We’re not cme here tonight. So yeah, say we can say whatever we want.
08:43
All right, that’s good, because the presentation I got for you is not see me.
Bill Clearfield 08:47
Okay. All right. So so that’s, that’s, that’s the, you know, that’s him to see me a goddess and so, so we’re just to let you know, and anybody who’s listening who doesn’t already know. Our annual conference is March 25 27th. And Decker watch. You’re more than welcome to come or, you know, it’s also online. We’re in Las Vegas at the Flamingo Hotel. Put on in the chat before we go the link for registration. And we have a superstar lineup. You you’ll you’ll recognize some of these names Kathleen O’Neill Smith, Felice Gersh, if you know anything, you know, anti aging medicine. We have Jacob Teitelbaum. We have Thomas Levy. We have Andrew Campbell. I mean, I’m doing pretty damn good here. It’s pretty great. And maybe we maybe we can we can even twist your arm for something. So and yeah. Oh, and well, we go and we have a preliminary from Peter Macola. He keeps telling us he’s coming but I can’t. I can’t pin him down. Like to a time so this, everybody but our speaker here. And so I’m like a broken record, as you know, are we’re here every Tuesday night where the American Osteopathic Society of rheumatic diseases and the Integrative Health Alliance and I’m sure our patriarch Dr. Burgess, we’ll be along any minute. We have a special guest tonight. This is Brad Watts and he is the your I’m going to let you introduce yourself. You are
10:48
clinical applications at bio genetics, and we’re a nutraceutical company and we start making solutions for people that are out in the trenches every day laying down with patients. And
Bill Clearfield 11:00
that’s awesome. So our group although it has has this kind of stuff, you name it. There’s only two rheumatologists left and I think only one practicing out of the original group. This is actually our 50th year leave oh my gosh since 1972. And so it’s we’re we’ve you know, we have kind of a long history. Some of its not so terrific, but history not. So and I’m going to let you it’s a little bit after five, we’ll have folks showing up for you know, you know, as time goes on, I’ll let them in. I usually mute mute everybody out, except for you, the speaker and we are going to let you introduce yourself because you know you better than I do. That’s great. Like but like I said for the group. Dr. Watts is quite prolific as a speaker. He has Casual Fridays, right? Yes, get that right. That’s right. And he’s got a zillion lectures on you. Can you name it? on everything? Everything integrative medicine. I mean, it’s unbelievable. He’s just covered just about the whole thing. He’s his he’s his own his own, you know, a Thai American Academy of anti aging medicine all in one. So I’ve listened to some of his work. It’s really top notch. It’s terrific. If you’re a newcomer it’s it’s simple enough to understand and if you’re an old user, like me, you know, just I would there’s always things to pick up. So with that, I’m going to let you Dr. Watts you know, take over if you need to share the screen at all.
12:48
Yeah, I’m going to try to go ahead
Bill Clearfield 12:51
and that there if you have a PowerPoint, yeah, whatever. And you look like you’re not young enough to know how to use this thing. So and I’ll keep myself quiet.
13:04
All right. So let me click in here and you just let me know if if you guys disappear. All right,
Bill Clearfield 13:11
and the only thing we’re going to ask is it okay if we record it because we like to put it on our website. So it’s gonna say recording and, and for now, take it away.
13:22
You’re all right. Thank you. So today what we’re going to talk about obviously, is going to be human cell and tissue product intervention as it relates to taking care of patients. The everyday patient, right. And so before we get started, I want to talk about how to pair nutrition and lifestyle intervention in a human cell and tissue product. You know, centralized intervention. And so we’re gonna talk about that today. This is something that we have been able to generate with biogenetics.
13:56
I mean, for the last couple of years, we’ve been just serving practices that specialize in this and so I’m excited to be able to talk with you guys about this today. So I’m Dr. Brad watts of bio genetics, by the way, and, and I am a chiropractor, I’m a specialist in functional medicine or clinical nutrition. And it’s the only thing I’ve done for 12 years, and we’ve seen 1000s of cases in consultancy and otherwise and so excited to be here so thank you Dr. Clearfield, obviously for given a platform for this. That’s great. So all right. So we’re gonna get through some of this here some FDA information regarding supplementation as per usual, and nothing out of the ordinary there but gotta give the FDA their their two seconds there. So here we have something that I hope in an integrated clinical setting is not anything new for anybody that’s listening to today’s broadcast and, essentially lifestyle and genetics. is what’s causing United States to get flushed down the toilet right now, from a healthcare perspective. But I also want everybody to understand that lifestyle and genetics the same thing that got us into the pickle is what gets us out of the pickle is interesting that you know, most healthcare providers understand lifestyle and genetics are what put us into a position, whether it be you know, arthritic issues or whether it be obesity or diabetes or anything like that. And it’s just it’s interesting to me that that’s not also, you know, first line of thinking when it comes to resolution, so, I’m out to change that. So my mission in life is, is to make sure that people get this image burned to their retinas. And is this you have control over the expression of your genetics and and it’s pretty exciting. So when you can show patients this in real time, apathy tends to walk away real quick and so I appreciate that. So anyway, so see where we are in this today. This is what we’re going to be talking about is how from joint destruction situation, human cell and tissue product and nutrition compare together to point this patient from the red side, right back to the right side of your screen, moving these patients toward wellness, to obviously that’s going to be, you know, our strategy here. The problem is, is that when we talk about nutrition and putting it into practice of just in a general medical clinic specifically, and I don’t really want you to be too hard on yourselves, right. But in any practice that doesn’t start from the ground up specializing in nutrition, what happens is, is people try to reinvent the wheel, so to speak, and make it more complicated than it needs to be. And so we end up with, you know, a shift pattern that looks like this. So people trying to integrate their practice, and it’s crazy. And there’s no systems or the systems are 19 layers deep like this one or 20 layers deep in patients can’t participate because nobody knows how it works. And so anyway, what we’re doing at biogenetics is we’re simplifying this and we have a plug and play lineup of nutrition products that specifically are targeting patients that are dealing with number one degenerative arthritic conditions number two neuropathic neurogenic, pain issues, for amatory weight loss, whether that be you know, the results of that being obesity, diabetes, etc. And then also cognitive decline. So the plug and play nutrition programming that we offer is certainly going to be region support, which we’re going to talk about tonight, not really about the region Support Kit, but about mechanics of it, how it works, and the metabolic clearing program. So if you want more information on those things, obviously we have a lot of education surrounding that and how to plug and play with your patients. So what I want to do is I want to start out with a couple of these things that the younger generation younger than me even are participating on a daily basis and these are memes and I have a couple of them that I want to show you because really we’re going to talk about two types of patients tonight and I want you to get the idea behind this before we go. So the meme always starts out like this. There’s two types of people in this world, right? You have the person on the left, who has single word text messages to tell you something, and you’re the person in the right who’s an analytical thinker, and they can put their thought process into words and put it in a paragraph, finish a thought before they send it to somebody. And here you have what you’re looking at. I can laugh and say that I’ll be on the right. And my wife is definitely the person on the left here. Okay. So I want you to see this. Right. There’s two kinds of people here’s another one for you. We have the person that can wake up at 7am with one alarm, then you got the person with the five alarm scenario. And the two kinds of people continue to demonstrate who they are and what they’re up to. Here we have the email situation once again, I will say that the one on the right hand side is more along the lines of my wife. She’s a clinician as well so I can pick on her a little bit.
19:15
But we get this Okay, so I want you to see if you can identify yourself in any of these things. Because when we look at the two types of people, we still have to figure out the people that you work with as well. Okay, and here we are looking at that. You have two types of case managers and an integrated clinic. You got one person on the left hand side that walks into the room with the patient and they say, what, what do you want, right? And then you have the person on the right here who’s just excited. Because it’s Tuesday, and it’s the best Tuesday ever, right? And so somewhere in the middle of that is probably somebody you want to work with. Now, if we can pick how you participate with text messages and emails, if you can pick the people that you get to work with, then you also got to think about the people that you’re admitting into care into practice, especially from an integrated or from a region centric perspective, which is really what we’re going to focus on today. And, and so what’s interesting to me is that, that same way that we have case managers in an integrated clinic we also have two types of patients. And so the two types of patients that show up specifically, are the guy on the left, right, which is the every man and then the guy on the right, which is a 70 year old marathon runner. And when people are in an integrated practice, like what they’re dreaming about what they’re dreaming for, is the marathon runner, right? His life is basically in order. He shows up, he’s got knee pain. Why? Because he’s been putting in the miles, right and he’s kind of an isolated issue. His knee pain has a mechanism that everybody can understand. And you look at it and you say, hey, that makes sense. Okay, that makes sense. But the reality is, is that for every guy that you have like this, that’s a 70 year old marathon runner. You have 100 patients that are like the gentleman on the left hand side, who might be an accountant or a lawyer right, or a bus driver or whatever. And this gentleman sits for a living, and this gentleman enjoys nutrient dense foods. This gentleman, you know, might be on three or four different medications at this point. He’s getting ready to go into retirement. It looks like you’re maybe he’s, you know, 6065 years old, and he’s trying to figure out what is his retirement look like? And you all know what his retirement look like, looks like. It looks like him managing chronic disease. And so as we go through the process here today, Modern medicine has done some pretty amazing things with human cell and tissue products that I’m going to talk about. But what I want you to see is that the fate of those interventions, is really
22:04
this gentleman’s lifestyle. Right? It’s really what he puts in his body and it’s a pretty interesting scenario that bears itself out in the medical literature. And we’re so we’re going to look at a couple of pieces of that today, right? So I want you to keep this guy in mind. Okay, because ultimately, this is the person that we’re going to have to serve. And, you know, somebody’s got to save this guy too. Alright, so for all of those of you that are heavy in the maybe in the region area or focusing on integrated side as it relates to nutrition for joint health, etc. You want to make sure that you are seeing your patient clearly because companies that are producing human cell and tissue product interventions and materials, marketing materials, they never show you this guy, they always show you the marathon runner, and you get excited to get in and you know, work on some specimens. Okay. And and sometimes that’s not the case, right? For the majority of us, that’s not the case. So there’s two types of patients that I talk about. So there’s a question that I often get as we look at human cell and tissue product intervention in food, and it says How does food based inflammation turn into targeted joint destruction and and really the auto immune researchers, they’re the ones that understand this better than anybody because they’re the ones that study those pathways. And so what I want to do is just highlight a couple of points here, and we’re really going to dig in and the functional aspect of this. Okay, so coming from any any of these titles, you can just punch them into Google and you can find those, by the way, okay. But when we look at autoimmunity, and we ask how does food based inflammation like how does somebody eating food that their physiology physiology is not compatible with? How does that go from my gut? is swollen to targeted joint destruction? And ultimately, that happens through the recruiting or the development of auto immune responses. Now, our testing is pretty interesting when it comes to auto immunity. But you know, in in a subclinical realm, okay? Life exists on a continuum, right before anybody ever has antibodies to a tissue, they have to have had that instructions manifested, right. So the DNA expressing itself and we start to see tissue you know, starting to come under attack. And even before we have, you know, clinical levels of antibodies while th one activity recruits th 17 activity, and that happens when the repeated stressor the inflammatory mechanism doesn’t go away. So we have this innate intelligence right you have th one activity, this innate immune system, situation where if you sprain your ankle, your your ankle swells up like playing basketball, if I sprained my ankle, my head doesn’t swell up. I just localized localized, but when that localized reaction is in the gut or ends up with you know, NF Kappa Beta activity that hits the bloodstream, and we’re going systemic, you know, all over. What happens is that if that th one activity doesn’t slow down th 17 activity is certainly recruited kind of like the military, right? You go from general infantry to you want to go to the next level of that all of a sudden you want to be a ranger, or a Greenbrae soldier or something like that. And what happens is this specificity starts to show up, and the more specific the immune system becomes, the more we allow it to specialize, the more targeted the destruction becomes. And it’s an interesting process. To watch itself bear out in your patient base, because you’re not seeing a lot of autoimmune joint destruction in you know, 10 year olds. Right. You see some of it, but not as much as you see in a population that’s 70 or 80, after they’ve given you know, the epigenetic switches a you know, a workout for 60 years. So, just looking at this, I want to understand that th one activity will ultimately recruit th 17 If the stressor doesn’t leave, and that’s where integrated practitioners have an opportunity to step in and really improve people’s quality of life. Okay, so, what we look at here, just wanted to note a couple of different citations here, but when we have th 17 cells, right enhancing differentiation of osteoclasts via joint specific mesenchymal cells, this is the mechanism, right? This is the doorway to chronic joint destruction, not even in an auto immune setting itself. This is the doorway to auto immune joint destruction. And what’s so interesting about this is that it doesn’t take a lot for you to recruit T 17 activity. All it takes is chronic exposure to an antigen or chronic exposure to maybe a foodstuff that. Your body is not a fan of and people are not sensitive. People are not sensitive to the things in that lifestyle. That are driving these reactions. But if you can take somebody that’s you know, sensitive or allergic, not even an IGE allergy if it’s even ag G or IGA. Somebody that takes a sensitivity to something like corn, right? You know, I live in the Midwest, and so you get 14 different types of corn growing all over, just all around you. And it’s super interesting. You know, the different responses that people get depending on where they get their products, right, but if you’ve take somebody that’s sensitive to corn product, and they’re eating chips, just constantly because that’s their snack, and they can’t figure out why they start having all of these a doctor I got the Gout or whatever it is right. And they get diagnosed with inflammatory conditions where they’re put on medication specifically to downregulate. That one, really, what we need them to start thinking about is how to stop pouring gas on this pathway. And it’s really interesting. So I work a lot with, you know, a variety of testing as most integrated clinicians do. And you know, it’s an interesting way to assess your patient base, but what happens when they’re that that lawyer, that accountant that we looked at, you know, and they’ve already been doing this for 45 years, and that th 17 activity is like, That ship has sailed, it’s not turning off, you know, relatively easily anyway, and the destruction has already been taking place. Right? We look at that mechanism and what’s actually causing it. So we have these two different layers of inflammation that I want to look at. Right? The first layer of inflammation is that immune mediated one where you start to see you know, the presentation of foodstuff or mold or maybe as a tick bite or something like that. You start to see a presentation where the immune system adapts in relation to that, but then we have this other one or the other one where it’s like hand and mouth disease, right? So this other one where you eat food and you breathe oxygen and you mash two together and you make ATP, which you’re seeing here, ATP supply and these little green, little green balls that you see coming out of the mitochondria here. We also have this free radical damage right now. I have a little two year old at home here. If you hear anything, by the way, it’s probably
29:39
his mitochondria look like this right as mitochondria look like his skin, or the foster Tata choline that makes up these membranes is like plump. It hasn’t been damaged. Over time though. What happens is you start to see people participating in this mechanism where the mitochondria become dilapidated, like a ship with holes getting blown in the side of it. And then really, when we look at the lack of antioxidant therapy, you know, frontline therapy as people are aging, this is what you’re seeing mitochondria breaking down ATP supply shrinks. We have a truckload of reactive oxygen species being produced, and that inflammation. Okay, if I can say something controversial, if that inflammation is not at least 50% of chronic disease, then I’ll be very shocked just in what we’ve seen over the last 12 years. Okay, I’ll be very shocked. So what we see is, is that there’s room for either the inflammation associated with metabolism in your body, or there’s room for the inflammation associated with your lifestyle. You got these two different paradigms that I want to introduce you to and when we look at these things, they both have a similar result, which is tissue destruction. tissue destruction. Alright. Hey, guys, still with me? I just want to make sure you get a thumbs up or yeah, you can hear me Dr. Clifford. If you’re there. We’re all here. Okay. Just want to laters
31:12
So, all right, let’s click on here here we have my graphic representation of our immune system that we just talked about with the recruiting the th one and th 17 activity and traditionally medicine, you know, looks at this now like the immune system is so complex, we can’t organize it. immunologists are sitting in their labs by themselves for two decades and, and they come up with this idea to explain it to the rest of us where they’re like, hey, it’s like th one th two teeter totter and life happens in that balance there. Okay. And it turns out that it’s not as simple as they made it for us. Right. But we have these naive lymphocytes at the top of the page here the CD four, and in you see this thick yellow arrow over to the th one activity, and that’s because this onramp into immune system and based inflammation is generally targeting this pathway. Right we go from a naive, you know, cell structure into a th one response relatively easily. Like you could trigger that with just repetitive stress. Okay, but over time you see this th one activity recruiting th 17 and we get this cycling back to th one there are a lot of people that get stuck in this mechanism and we would look at them as th one dominant when we’re talking about autoimmune diseases or otherwise, but it’s not really that they only have th one activity is that th one activity keeps feeding back into itself through this th 17 loop and we don’t get the massive differentiation into th two antibody responses or you know the classic allergy situation with th nine. Okay, so when people are stuck on this left hand side, they can go a lifetime with destructive inflammation and nobody ever finds it because everybody’s looking for rheumatoid but nobody’s finding rheumatoid even though they have all of the symptoms. And these patients are left to sit there and suck on. You know, their medication. Okay. And like just sit there and bear it. And ultimately, it doesn’t need to be that way. If we can look at them from a clinical perspective. You know, looking at let’s look at them from a diagnostic perspective rather than a therapeutic perspective. So most clinicians that I know are great at the therapeutics, but not a lot of them know where they are in the biochemistry map. Like they can’t look and say you are here. And if you’re here, then we got to figure out how to get to our destination. Most people don’t have that in their brain. Right? But that’s changing because integrative practitioners like you guys are starting to bring some common sense into the everyday practice. And if we look at integrated health as anything, I hope we look at it as the common sense model. Right. So looking at this, this th one to th 17 mechanism is where we can make or break a lot of these these joint destruction issues in the long run. Now, I’m going to show you some of this in the medical literature in a minute. But what you’re going to find is is that as th one activity begins to grow, the reason it’s growing after the antigen presentation or after even if a patient changes their diet, right. The reason that th one activity continues and remains is because of that mitochondrial mechanism that I showed you, reactive oxygen species just wreaking havoc, okay. So this th one activity we get, we basically get a double dose of it. And so I just I want you to see that before we get into this. So here’s a graphic of how I explained care to patients, and how I expect explained care to clinicians that we’re teaching. And essentially, it’s a root and fruit graphic. So if you can see a tree in this, just use your imagination a little bit. You see the tree trunk here in the branches, and then we got the fruit showing up over here. Okay. So one of the things that you’re going to find is is that in modern medicine, in natural health care, right, by the way, natural health care has completely gone in the opposite direction. From what I feel like they should and for the most part, natural healthcare is trying to be allopathic medicine, but with less intense interventions and it doesn’t work. It’s like a squirt gun on fire. Right. So you got to be mechanism based, which is what integrated health is all about. And if you look at this, you can see the mechanism here and patients can understand this. So they show up with obesity issues, they want to lose weight or to take the pressure off their knees, whatever it might be. They have joint destruction. Maybe they got diabetes, high cholesterol, high blood pressure along the way. But the point is, is that these are fruits of an underlying issue and for patients to miss the underlying issue really doesn’t serve them appropriately. Right. And you guys know that but what you’re getting is this prolonged th one activity starts to recruit inflammation that drives the obesity mechanism. I just did a webinar the other day on how neurologic inflammation you know, drives obesity, apart from exercise and diet. It’s amazing. Okay, so here we have this prolonged inflammation that might turn into auto immunity and get joint destruction. Maybe get auto immunity associated with diabetes or otherwise. But seeing this, right you can have straight th one activity that drives patient in all of these directions. What we want to do is we want to figure out how to lay an axe to the root of this mechanism rather than just continually medicating with nutritional products. The problems here like here’s your stimulant for your weight loss issues here we have, you know, straight can Driton you know, don’t do anything with your diet, but here’s conjoint and sulfate for your joint issues, and then you know, your cinnamon pills and all the stuff for diabetes. And it’s like the body’s more complicated then you know trying to douse the candles when they get laid. I got to figure out how to lay an axe to the root of the mechanism here. And so that’s what I’m going to show you in the medical literature as it relates to this human cell and tissue product intervention today. Okay. So just for what it’s worth, I’ll send you the slides. If you want Dr Clearfield but basically, if you can show patients in a root and fruit mechanism like this what you’re working on, it’s like it’s it’s a no brainer for them. And when you make it a no brainer for the patients, the intervention is completely understandable. Right They will tell you what needs to be done before you can even get it out of your mouth. Right. It’s amazing. So anyway, here’s your gentleman once again with all of the fires his whole body is on fire. He’s got standard American lifestyle driving the inflammatory situation. So remember th one activity is supposed to be localized for local tissue inflammation like sprained ankle, but this gentleman’s if you look at him, you can tell his physiology is not real happy right now. And part of that is is because the localized inflammatory issue has gone systemic. And in this systemic issue is going to require you finding the right axe, right delay it to the roots of the tree. So just so we can get that. Right. So looking at this I just wanted to highlight a couple of things that these researchers had to show us in 2009 Because it seems like such a long time ago that people started talking about the promise. The promise of stem cells in this situation that showed up, you know, the promises stem cells, where has it gone, right? We’ve got all of the regulation and stuff that showing up now and companies can sell product and then they can sell product and now they can and they’re back online, and then they’re turned off again and then we get this this situation that shows up but what I wanted you to see from 2009 is that these guys had a pretty
39:16
bright outlook on what was gonna happen with stem cell therapy. And it’s because they were looking at pluripotent stem cells and and we’re not doing a lot with those right now as it relates to clinical intervention. But we are doing we’re seeing a lot of that in the studies. Okay. So when we look at pluripotent stem cells, obviously they can become anything in the adult body and multiphoton are the ones that we’re looking at is being used clinically right now because obviously you don’t want to like fun cancer and crazy stuff. So when we look at this, the cell sources characteristics differentiation. And therapeutic applications that they discuss are pretty interesting because they show you in this, this review here, they show you what we can do from an epigenetic perspective to turn them off and on. Well, if we can turn stem cells, human cell and tissue product off, we probably want to know about that before we go around putting $3,000 of tissue into somebody’s joint, and then they turn it off with their lifestyle, because there’s two types of inflammation in the body that we discussed so far. And one of them is helpful and one of them is not helpful. And so we’re gonna expose that here as we go. Okay. So anyway, when we look at this, from a multipotent stem cell, you see here, the differentiation into these multi potent ones. This is what FDA has essentially allowed people to work with and you get the you know, bone muscle blood version, but this is this is what the FDA has allowed people to work with. Okay, this is really where the magic is going to be. Once you figure out how to make sure that you know people’s epigenetic soup that we’re putting these into, don’t funnel them in the wrong direction and and I’m kind of excited about it. So the next 10 years are going to be like golden era for this kind of stuff. And you guys are really, you have an opportunity to be at the forefront of it. So I think that’s kind of cool. But anyway, when we look at multipotent stem cells, we want to really think about the the term that I mentioned the epigenetic soup that we’re introducing these into, we want to think about these in terms of like, like a seed being planted into the soil. The soil is why we can’t use pluripotent stem cells clinically the way that most people would want to right because the soil is what’s determining what these things become. It’s so interesting. So as in a lab, I won’t say which company but I was in a lab. And
41:53
you know, they make human cell and tissue product interventions for clinicians all over the world. And as in a lab talking with Doc’s in the lab director and I said What is the biggest problem right now that you see in this industry? And he chuckled a little bit and he said gut health, gut health. And I had to I had to laugh a little bit as well because gut health is curious. There’s a homing mechanism that I’m going to show you here with stem cells, that that homing mechanism. You put stem cells into somebody’s joint tissue, right if their guts on fire, those stem cells, they’re packing up, right, where are they going? They’re going to the source of the largest. You have a site of inflammation if you put it that way, right in, they’re intelligent and they follow the signaling pathways that are in your patients bodies. And so we have this mechanism with leaky gut and all the different things that are going on especially when you look at the gentleman that we’re talking about here, where we have, you know, Lippo polysaccharides, entering into the bloodstream, lighting, NF Kappa Beta on fire, and that’s going to total body and it’s all sourced in the gut. Okay. And so we just we see this play itself out over and over. And we got to ask, How come that patient’s own stem cells that he’s making? His bone marrow that he’s making? How come those stem cells aren’t doing the job? How can we start to come to you, where you’re going to introduce you know, a new product, a new version of it to his body? What was the difference between him being able to participate in it on his own, and now he needs you. Okay. So, a couple of things. I’m not going to read all of these, obviously, but I just want to highlight some of these things. Endogenous stem cells right now, are a necessity for a lot of people that are struggling because the cell trafficking mechanism for their own stem cells has been turned off, right as you’re gonna see here, reactive oxygen species and the suppression of substance P will turn off your own stem cells ability to locate sites of inflammation and participate in tissue regeneration. Right. So that’s essentially what’s happening. They need you because they’ve turned off their body’s ability to signal stem cells to traffic in the right direction. Pretty interesting. Okay. So in the aging process, inefficiency in the endogenous stem cell mediated healing mechanism emerges from a variety of impairments that accumulate. I think that’s the key term right there as accumulate in the process of stem cell. Self renew function in differentiation. Okay? Pretty interesting. The intrinsic pathways that are present here are being told for a lifetime to shut up. Go away, be quiet, okay. And and your body listens pretty well after a while. So these guys here in this 2017 article talked a lot about reactive oxygen species and nitric oxide, and in really, what happens with the body’s ability for those homing mechanisms, okay, so imagine you are that patient that I had on the screen here. Imagine you’re that guy, and you show up, you know, to the doctor’s office because you got a bum knee, and you think it’s an old football injury. Okay, when it might have been an onset from an old football injury, but really what’s driving it now is the constant Miller Lite, right? Or the patient having too much pizza hut on a daily basis. Why? Well because it’s right next to the office, right? And so anyway, the old football injury becomes a chronic situation and now we have this degeneration taking place because reactive oxygen species build up and breakdown in nitric oxide pathway is driving NF Kappa Beta activation in these mTOR pathways. And we get these tissues just disintegrating right like wet paper. Just disintegrating. And ultimately these patients have to be introduced either to large amounts of antioxidant therapy, or these patients have to be introduced to human cell and tissue product interventions. Right and hopefully they stay localized now everybody knows that, you know, when you’re taking anti inflammatories or etc. You can’t participate with humans healing human cell and tissue interventions effectively, because you turn off the inflammation that’s inherent in the intervention. The cytokine response in that injection is going to be turned off by those medications, anti inflammatories in general, we’ll just classify that in general. Okay. Now, antioxidants have the capacity to do the same thing. But remember antioxidant therapy as a means of anti inflammation has the ability to be trafficked if I can say it that way. And has the ability to participate with human cell and tissue product intervention as opposed to down regulating the cytokine response. super interesting. So if we have I don’t have the slide here today, but if we have a an inflammatory response and a cascade and we see that, you know, the entrance to the cascade and then like 60 mechanisms wide on the bottom down here, if we go with an anti inflammatory medication that’s pretty high up the cascade and shuts everything off, okay? But if we’re using products, like glutathione, when n acetyl, cysteine and vitamin C and R lipoic acid, etc. If we’re using products like this, right, those are so far down the cascade that they are considered selective. I get that selective. That’s pretty interesting. So that means that you can get your patients benefit, right in controlling reactive oxygen species and tissue breakdown while also pairing it with human cell and tissue product intervention that gives them the capacity starts in tissue regeneration without turning it off. Okay. Now, let’s take that a step further because if we can put, you know, here, if we, if we look at this mitochondria, and we see all of this reactive oxygen species build up, that’s metabolic dust. Okay, like how long are you willing to live in your house before you dust? Right? How long are you willing to do that? Well, the same question you got to ask patients and it’s something that I ask patients quite often How long are you willing, right to live with a body that is producing large amounts of metabolic dust like this? Without cleaning it up? You got to put some dust busters in there and get busy. Right, what are the dust busters? And the accidents? Right? Something that’s going to get in there and vacuum up all of this Metabolic dust, right and think about this, even if you decrease their overall you know, RMS load by 7% 12%. That’s pretty amazing when we’re talking about the body’s innate capacity to heal, right and giving a little bit of room to breathe. And you know, really start healing the edges of the cut together, so to speak, even though this is a metabolic cut. Right? So just interesting. So when we look at the variety of epigenetic modifications, talks about here in chromosome architectures, what they’re looking at is a gradual increase in inflammatory burden over time
49:36
driving down, alright, the tissue repair and anti aging effects of substance P. substance P is that homing mechanism that causes the stem cells to traffic toward the sites, right of intervention are where they’re required. The problem is like get this you got knee pain required because we maybe were bone on bone at this point and the tissues not regenerating the way it’s supposed to or in an ideal world would. Those stem cells are made like four inches away? Right there, they’re made like four inches away, and they cannot find that site of inflammation effectively because we lose our ability to participate with this little bug or substance P. So, when we see this, we got to ask the question what turns off substance P activity because if you could turn it back on, you probably want to participate in that, at least in a similar mechanism. Right? And just really interesting. So if you guys have never read this study, just grab it on PubMed and and just take a peek really interesting findings that they have here. I wanted to highlight this substance P What causes substance P to take a nosedive and its functionality, right? Well, modifications to DNA and non coding RNA mediated mechanisms, as they say, are epigenetic events. That play important roles and regulation of the progenitor cell function by changing chromatin structure. Okay, so we start seeing changes to our DNA expression, right because we start changing chromatin structure and substance P starts backing away from the party so to speak, right? The epigenetic changes in adult stem cells are critical during aging because they alter the function clonal composition and lineage of stem cells, they alter the lineage of the stem cell. Right that’s the key line right there. They alter the lineage of the stem cell so if we have epigenetic situation that’s not allowing our patients you know to heal like this gentleman I told you is got a sit down job is sit down job is ultimately leading him to a life of like luxury, right so you see sitting down is a luxury on the job, right? Our body is definitely not it’s not set up for the sit down lifestyle. Okay? When we start looking for like comfort, the body starts to fall apart and that’s interesting thing, but this is why we start seeing the DNA changes here, the epigenetic switches, just changing the expression. The lineage, fate of stem cells is what I want to talk about, is regulated by intrinsic and extrinsic epigenetic modifiers as you see, and what I just I find in this is that if you give somebody a shot at adjusting their lifestyle for tissue regeneration, not a lot of people say no to that. The problem is, is that we have to then quantify what lifestyle intervention is required. What does that even look like? What does that even look like? So hang on here for a second. All right. So I’m just gonna plant that flag there and we got to ask that question. We got this guy. He’s got a tissue regeneration issues he wants human cell and tissue product intervention. He wants to do some lifestyle aspects with it, I’m going to recommend it at least. What does that even look like? Okay, substance P here, right is expressed in a variety of non neuronal cells, Condor sites, osteocytes, osteoblast, osteoclasts and mast cells. Right. Now, I wanted to throw that out there because if substance P receptors are present on these tissues that we’re asking these tissues to like wake up and do something. We got to figure out how do we get substance P activity to rejoin the party? Right? It’s neuro immune modulation is the name of the game. So I mentioned a presentation that I had recently given about obesity being driven by neurologic inflammation, starting the central nervous system and how that can be turned off by exercise, which is why the exercise industry nets seven to 10 pounds weight loss on average for anybody when people need 25 to 30 Okay. So looking at this substance P is also participating in the same neuro immune modulation mechanism. And
54:17
you know, when that when that inflammatory situation is present, these people are just falling apart because substance P is taken off the playing field. Okay. So taken off the playing field. Now, pain is supposed to be a modulator or a signal that says hey, substance P, let’s show up here. I experience some pain so that stem cells know where to go. Right. I remember an injury back when I was a kid snowboarding and and my knee swelled up like the size of a melon, it was huge. It was huge, right? And that huge inflammatory situation was my brain signaling through the immense amount of pain. Signaling Hey, stem cells, this is where we need to participate. But if you look at substance P and blocking pain signals and what we do basically from a medical perspective at this point in time, people are living pain free lifestyles through chemistry. That decreases some of the activity of substance pain and that don’t want to discount that right or substance P I should say. So anyway, so here we are back at our tree root and fruit mechanism. Gentleman’s got some tissue issues going on. Okay. Does he have food allergies? I’m gonna look around does he got mold issues? I’m gonna look right Lippo polysaccharides. almost everybody’s got lip polysaccharide issues. And what’s the look like as far as alcohol on his ethanol intake and what that’s doing to his gut. So from a diagnostic perspective, I don’t work for these guys. I’m not affiliated with them, but I really appreciate the diagnostic workups that you can get from a company like vibrant wellness, okay, where you can look at total talks panels, that look at biotoxins, mold issues etc. Like that, along with, you know, maybe heavy metals and environmental toxins. Those are the biggest ones that I see right now. Especially in my area of the country. You look at organophosphates being used spread on the field, essentially to produce crops. And these things are driving mass degeneration, both neurologically and musculoskeletal degeneration in an entire an entire generation of people right now. And it’s a massive transfer of wealth that’s taking place by the way between the baby boomer generation and everybody that’s willing to sit there and serve them. Okay. And I don’t think it needs to be that way. If you can look at talks panels and actually do actual workup on patients in a way that is meaningful for their lifestyle. How to generate a lifestyle. Well, if there’s something in your body that’s not supposed to be there. We should probably get rid of it right? And so if we can look at tox panels, or they have Zoomer profiles, which are amazing as well for IgG, IgA, even IGE and looking at food issues, the the diagnostic scenario that’s available to us in 2022 is just remarkable, right? If a patient’s willing to participate, and that’s where a slide like this comes into play is showing them right if you’re going to lay an axe to the root of this tree, your lifestyle plus your genetics is creating this tree, the obesity, joint destruction and the diabetes issues. So what does that mean? What are you going to change in this equation, lifestyle plus genetics, you can change your lifestyle, right? And ultimately, in order to figure out how to create a lifestyle that people can participate with, that gives them the ability to have proper health and healing. You got to have the diagnostics to do it and so in my opinion, the biggest hole in integrative therapy is running tox panels on patients, okay, it’s the biggest hole. By the way, I’ll just say this. When a patient sees that there’s something in their body that’s not supposed to be there. Right. They know what the treatment plan is and they can’t say no, right? If I show you that you ever get phosphates in your body and those are diabetogenic. Okay, they’re diabetogenic. The FDA knows the diabetogenic. It’s from their own research, and you go home at night and you’re like, Yeah, I think I’ll just risk it. Or you’re not gonna do that. I think I’ll just risk it. No, you’re going to figure out a way to support your body’s ability to process slash remove slash avoid these diabetogenic compounds. Well, the same thing when we look at things at target tissue destruction, okay? We’re going to avoid those. Alright, so anyway, I’ll get off that horse. there for a second here is the situation, substance peel, make a comeback. But most of the time, it will only happen in autophagy. Okay, here’s the problem. If we look at human cell and tissue product interventions, and you’re like alright, we got to do a lifestyle here. How many of your patients are going to be willing to fast number one, and for the appropriate amount of time that’s required? Right. So guesses on fasting like if we had for all live here in a classroom, I would ask you, most of the time people ask about this and they say, I don’t know three days of fasting.
59:26
Not for substance P to make a comeback? Not three days, seven days, how many of your patients are not going to eat for seven days? The answer is none. Okay? Like I like to do stuff like that, but it’s more of like an exploratory process. And figure out what are the boundaries? And for me, I will tell you that after three days, I got draw the line, kind of draw the line. And and I find that for most patients, they’re not willing to go more than 24 hours. And so this this like, fleeting autophagy is really where we’re at. Okay, so anyway, toffee G here is a non has been viewed as a non selective housekeeping process. But really what you want to think about is our viewpoint on it is evolving and increasing evidence demonstrates that autophagy is an active program. Program. See, that’s interesting because a program means that it’s like it’s set. Right? It’ll deploy itself when a demand is put on it. Okay, and the problem is United States. We don’t ever put a demand on that program because well, I was pretty good. I should pretty good. Have a lot of options. So, what it requires autophagy is lack of comfort, right. So if we remember I said that you know, immunologist gave us that th one th two teeter totter understanding and maybe if we have a new teeter totter in integrated you know, therapeutics, we can think of that as, like comfort versus, you know, discipline, like this balance here, comfort and discipline, because ultimately, if we have an opportunity to put our patients into autophagy, they’re going to get better. Now, one of the things that we see with autophagy is that you have cell membranes that begin to have pretty awesome renewal process, mitochondrial renewal, I mean, look at the envelopes that they’re in. And then we also look at actual cell structure cellular structures, having the ability to participate in that homing mechanism. Once again, with substance P. Now, there are other ways that we can support cell structures, right without having our patients you know, requiring them to not eat for seven days at a time. And you know, and then they fall off the wagon and Old Country Buffet is back in and you know, and the tissue destruction remains. So it’s interesting because if we want to not turn off the human cell and tissue product that’s introduced to their physiology, we have to figure out how to get them participating with cell membrane therapy once again. Okay. So and ultimately that’s what we’re talking about here. So here’s a just a one slide. review of what we’ve talked about thus far. Okay. You got two patients one result, if, if we can work on the lifestyle of the patient that has the lifestyle that’s not compatible with health and healing, okay, so lifestyle plus genetics equals chronic inflammation, we get that ROI is build up and this is not even in patients who have like autoimmunity, or food issues. This is just in the general population. Right. And chronic general inflammation specializes by th 17 activity in the tissue destroyers. Right, their own stem cells are less viable because substance P is no longer acting as a homing beacon for the trafficking mechanism. RS degrades that stem cell potential. And so we leave all of that potential locked up in the tissue patient shows up to your practice autophagy is one option. Are they going to participate in autophagy? Sometimes they will but for how long? Right? We use plug and play cell membrane enhancement. Right so support mechanisms that we use with that versatile choline large doses of antioxidant therapy as it relates to vitamin C and R lipoic acid. And basically just giving the body building blocks to lay down new scaffolding structures so that when we start putting new tissue down, we start putting that layer by layer. They have the ability to participate in it right now the kit that talking about here was the first kit on the bio genetic slide that I showed you the beginning. But what we want to think about is ultimately, the I’ll talk about that in a second. But what we want to think about is ultimately we want to be able to support the patient’s ability to get through that initial inflammatory mechanism from the human cell and tissue product intervention without turning it off. Okay, that’s the point of pairing nutrition. So you have three options. You have no nutrition in, introduce the cells see how they do and it’s good and you get pretty good results, right? Like let’s be real. We have the other one where we could go through a root and fruit mechanism where we can do an actual lifestyle reset with something like our metabolic clearing program, and teach the patient how to make better choices and we actually get to the root RRS issues and then we have the third option, which is a plug and play. And you know, patient doesn’t really want to change their lifestyle. That’s all right. And we have this third option, that which is the region kit, as we call it here. Right now, I want to talk about these guys because these are liposomal and they’re put together in a way that allows for maximum absorption. And they’re very tiny and the lysosomes are so small that you can see through the liquids. And what’s interesting about that is that when liposomes are too big, you get cloudy tinctures and that defeats the whole purpose of liposomal. So we want to make sure that we’re able to bypass some of the gut issues that these patients are having, so that we can get the fossil Tata choline into the bloodstream relatively swiftly. Same deal with the vitamin C. Now vitamin C. In integrated practice. You guys probably talked a lot about vitamin C over the last two years but when we look at vitamin C, there’s a shutoff mechanism in the gut. And typically you’re going to get a flushing reaction associated with 1000 to 1500 milligrams somewhere in there. And then you won’t get that with a liposomal because a lot of it, it’s going to be absorbed in the mouth, through the tissue. layers in the mouth and then also the esophagus. So pretty interesting. The other aspect to this why we use these is because we’re trying to control Lippo polysaccharides that are lighting NF Kappa Beta on fire and creating most I say most bold statement, most of the inflammatory issues that patients are dealing with systemically from their lifestyle, right so it’s a pretty interesting scenario. But if we can get fosse total choline to start working its way down the esophagus and the stomach into the duodenum and start changing the output these local polysaccharides that are being created by gram negative bacteria in the gut, and you get a pretty good response. That’s pretty fun. So this has been consistently one of our best and most utilized products in the space just over the last couple of years since we built this. And it’s it’s been pretty fun. So I like the patient’s story. So if anybody does use this with their patients, make sure you send us your stories. I like hearing those things and it helps us make sure that we get the word out as well. So anyway, what I want to do is just briefly here, give you
1:07:02
Kim at bio genetics, right this is part of the crew here. So they probably don’t know that I put this picture up there for you but they sent it to me so that’s what we get. But anyway, Miss Kim is somebody that you can reach out to if you want access to any of this information. If you want access to any of our learning library we have a lord probably 300 hours of integrated education on nutrition. And it’s all classified and organized by conditions and, and interventions, which is kind of fun. So check that out. It’s all free by the way I’m going to do is email Kim and she’ll get you plugged in and organized that way as well. So one of the things that I’d like to do at this point Dr. Clearfield if you’d like is I got a couple of minutes left. It looks like if you guys anybody has any questions you want to talk about something as it relates to stem cells or nutrition, anything like that I’d be willing to do that.
Bill Clearfield 1:08:05
We have a couple of comments and questions when Dr. Southern asks do you use the outcome test?
1:08:14
Sometimes I will use the cat test and they do a good job at creating accessibility for patients. But one of the things that I like is the report structure that I can get from a company like vibrant wellness or Cyrax is a competitor of theirs that does a good job as well. And, and those reports are based off of a unique set of data. Right so our cat is based off of their own data and these other reports. I find it more targeted and organized. Report for patient consumption. So I’ll say that so but I have used okay, yes, I have
Bill Clearfield 1:08:58
more of a comment from doctor to tell you. She states that you have to work up to a seven day fast as patients are mostly insulin resistant. What do you think about adding ketones to get over the flu like hump?
1:09:10
Yeah, so that’s a good question. There are ketone products in the marketplace that do work well with that. If you’re gonna do fasting with diabetic patient, obviously there’s a whole bunch of issues associated with that. But, you know, ketones are certainly a way to circumvent some of the mess that shows up. So and they have some pretty good technology of flavor profiles for those two. So good.
Bill Clearfield 1:09:41
Then she states then proceeded to start with two meals a day and one meal a day, two days a week. And as you get easier, yes, that’s right husband doing that. They’re in their late 60s. And not likely to go over seven days.
1:09:56
Right. That’s good. Very good.
Bill Clearfield 1:10:00
So that, how about cytokine testing? Do you do any of that?
1:10:03
I do. I do science and testing. And since
Bill Clearfield 1:10:06
we’re allowed to talk about it, do you have any any companies that
1:10:09
Yeah, so for cytokines, I will use either vibrant wellness once again, or Cyrax. Okay, any other, you know, go ahead.
Bill Clearfield 1:10:29
Okay. Um, can you give us kind of a breakdown, so somebody comes in, and you have your detox suspicion? Yeah. Where do we begin? You know, some of us are old timers and, and we’re regular doctors and we’re just coming to this late so.
1:10:48
So let me get this slide up here for you. This will give us something to talk about. As we look at the root in fruit. As we look at the root and fruit mechanism, the idea that we can help a patient reverse the symptoms of their chronic condition and walk away from chronic disease is, you know, new and I say new like 1970. And in this idea of well, how do we do that? We’re gonna find out what the inflicting agents are right? So the testing is where we always start. So for myself, I’ll never take on a patient case. Unless I have data that backs up a this is what needs to happen so patient shows up. Dr. Clearfield you show up with a practice right? And in you say like, Hey, Doc, can you help me have diabetes and brain fog and my joints are driving me crazy or whatever? Can you help me? Well, I have no idea if I can help you. I have some suspicions. But I have no idea really. It’s going to require me to have some valid data in order to be able to put a treatment plan together for you because it might be three weeks. It might be a year. It just depends on what we find. And so I find a lot of value in doing tox testing, plus blood chemistry. So I use blood chemistry tests through a vaccine. If you guys want I built them for biogenetics through a Vixia they’re preloaded into a vaccine account. So I got to do is ask the rep to load your account with it. And it’s our basic blood chemistry panel that we’re able to get great rates on instead of having to bill insurance like two grand so we can get the testing for around 200 bucks. Some of them are way less than that even. But the point is, is that it makes it accessible for patients so that I can actually get a picture of their health. The blood cam gives me a snapshot as to where are you right now? Right and then tox panel tells me why for the most part, if I’m looking at chronic disease, if you’re looking at kids or you know like pregnancy issues, stuff like that, you know, then you start looking at less tox panel induced issues, you start looking at hormones, and you know that type of thing I would anyway. So, you know, those are the two basic that I’ll use tox panels and blood chemistry. Now, there are ancillary tests that you can run if the case calls for it. And sometimes I’ll do Dutch testing, which is hormone profiles based off of metabolites, not just free fraction hormones. Sometimes I’ll do organic acid testing, which is you know, an old favorite of integrated practice just depends on on what the patient case calls for. So all of that data, right, whatever is required without breaking the patient’s piggy bank, all of that data being able to give us a synopsis essentially, that says, here’s what’s going on, here’s why. And then we have to figure out what to do about it. Okay, so I looked at a case this morning, you know, where a patient has 95th percentile cobalt in their bloodstream. A How did that get there? Right. And secondly, some of the psychological symptoms associated with cobalt toxicity are destroying this person. And nobody looked in so they asked, usually by the time they get to somebody that practices in a functional space of the integrated space like this, the virus, they’ve already gone to everybody else. Okay. So they had a good battery of tests and stuff, but we looked founded. And so now what are we going to do? We’re going to figure out where the exposures coming from mitigated and then support patient’s ability to process phase one, two and three liver detoxification, and maybe harness a little of the entanglement as well. And you know, it’ll probably take them three or four months.
Bill Clearfield 1:14:51
Budget, the patient have any of artificial joints.
1:14:54
This patient did not. This patient did not. Yeah, it was
Bill Clearfield 1:14:58
there was a time when they were using COBOL was leaching out of hip replacements.
1:15:04
That is interesting. I’m I thank you for saying that as interest so
Bill Clearfield 1:15:10
that’s, you know, I ran into that. When I was in Northeast Pennsylvania we had a whole rash of cool you know, got to be a joke because we didn’t know where it was coming from. And it was it was it was actually from joint replacements. Wow. We have Dr. Foley is going he has to question he’s an orthopedic surgeon. He gives some insight into that. Yeah. But that’s the first thing that comes to mind when you say cobalt, I think artificial joints. So let’s search around, see if see if they have that.
1:15:40
That’s pretty great. So thank you. So seeing this
Bill Clearfield 1:15:45
back, he writes metal on metal hips causes this. So Wow. He wrote that so
1:15:51
thank you, doctor. So seeing this, right gives you you start to formulate a plan. Now. In that plan, you can communicate to your patient. So what are we going to do, let’s say this patient like in this little blue box that I have here. This was just an example. Patients got food sensitivities or IGE mediated allergies. biotoxin issues with molds. That’s a huge thing right now, especially below, like below Illinois, I’ll just say it with a mold exposures. Lippo polysaccharides. That’s almost everybody. And then blood sugar is a huge key for most of these cases as well. So rectifying those issues that you find on a patient laboratory report. And, you know, and if you’re not familiar with how to do that biogenetics has a feature. It’s a free service, which is pretty great. But it’s clinical consulting team. You get patient laboratory data, and you’re like, well, now what do I do? We’ll say how to do it. Right, even if it requires products that biogenetics doesn’t manufacture will tell you what to get and where. And it’s a free service. So I get to just talk to Kim, if you’re interested in that. But last year, I think we did, I don’t know 3200 cases, right through the clinical consulting service and it’s, it’s pretty good. So
Bill Clearfield 1:17:10
So Dr. Foley asked, is there an inflammatory component to osteoporosis? And if yes, how what what would a management course question?
1:17:19
So I will say in every case I’ve ever seen Yes. Are there cases where there might not be? I would suppose so. But in any case that I’ve ever seen, yes. And what we basically want to look at is the connection between direct kidney and gut and how they’re interacting with each other. And so what we will oftentimes do is run assessment measures to figure out is inflammation suppressing thyroid function or is inflammation destroying kidney function as it relates to managing calcium content? So that then we start looking at estrogen in how the body participates with those three as well. So how do you move a patient in the right direction? I’ll say it depends on the mechanisms that we find in the laboratory chemistry.
Bill Clearfield 1:18:17
kind of answered this already, but maybe one more time. Dr. Crowley is about the can we get it lab ID information that you use. So I guess the lab, if you go through that, you know which labs are your favorites that you found?
1:18:30
So I use the biogenetics a general screen for blood chemistry. And that one is at a Vixia of Axia is just a buying group. So you can you know, purchasing power with 1000 other doctors and that way you don’t have to pay crazy prices at LabCorp. Right and so your patients can get great labs for you. It’s at lab core but you know, you don’t have to pay exorbitant fees. And it’s pretty awesome. They have a great service. So I’ll use the basic biogenetics general screen there and look at all the major organ systems. Look at the inflammatory pathways patterns. What do we got going on there snapshot in time, and then I will usually run talks panels, there’s a panel called a total tox panel from vibrant wellness that will measure metals, mycotoxins and environmental toxins and this stuff that we find is it’s almost unbelievable. Unless you’re looking at it. You know, we see a lot of diabetes cases is this really low hanging fruit in the you know, the society we live in today, but also a lot of people that are getting destroyed by it and they need somebody to serve them. Well. If you’re doing that, there is a part of the tox panels looking at organic you know, pesticides etc. And, and these are diabetogenic as I mentioned earlier, these diabetogenic it’s a term that not a lot of people are participating with yet, but it’s been in the medical research in the literature for over 20 years. diabetogenic are diabetic genes, and organophosphate farming chemicals are right at the top of the list. So if I look at 100 cases in the next month I guarantee you 85 of them will have chemical toxicity associated with the diabetogenic effect. So it’s it is pretty wild. Like stuff I wish I would have knew 10 years ago, but thankfully vibrant wellness is able to put it out there at this point as well. So that’s pretty good. So I’ll look at that. And then if I’m looking at hormones, I’ll do blood and something called the Dutch test. And a Dutch test is at Dutch test calm and and they do a great job of looking at metabolites. You can compare that with your free fraction in blood etc. And you get a pretty good idea of what’s going on.
Bill Clearfield 1:21:06
Thank you so much. A couple of months ago I actually presented a case. It was a 34 year old woman who had all sorts of brain fog everything that you’ve been talking about it that present no she was 39 It’s been present for four or five years. We I did what I do and we sent her for a micronutrient test and I used I use Genova and they combined their micronutrient test with heavy metal testing and I accidentally checked it off. I didn’t even realize was the first time I used a new form. And it turned out that she had gadolinium, you know off the charts. And so I went and asked her she’d had three IV contrast MRIs about 633 to six months before all the symptoms started. So it was fairly sensitive. So she went to Stanford, they ran their own which showed nothing. And said, Well, she didn’t have it and you know, we didn’t know what we were talking about. But they were doing micrograms and I think we Genova measures that if I believe I got it right as in pico gram so and what much more sensitive. So any, and I presented a case here to the group I thought it was it was pretty interesting any but then getting rid of it is a whole nother story. That’s right. Any any experience with that at all?
1:22:35
Yeah. Two weeks ago, I had a case of the same thing. It was a kid that’s got a genetic issues 21 years old, and he’s got diabetes and his kidneys are getting destroyed. Right and so we look at some toxic panels with him and and one of those things, can you help me no idea but let’s find out. And he loaded with the same thing, because the doctors have been given him contrast studies to a month trying to make sure his kidneys don’t die. And, you know, pretty interesting scenario,
Bill Clearfield 1:23:09
kind of what kills them in the first place is contrast.
1:23:12
So, you know, it’s not my place. I’m just the nutrition guy. So it’s not my place to say what to do with that or not, but I tell them, hey, if it were me, I probably would consider you know, not taking pictures of them so often. Right? But anyway, when we look at that, we want to think about the removal mechanism. Especially in somebody that’s got sensitive kidney tissue already because the kidneys don’t usually come back very strong. You can rehabilitate them sometimes, especially in a 21 year old, but this sensitive little buggers, right? So it’s not like you want to, you know, put all of that metal into the bloodstream and roll the dice and see what happens. So we’ll use glutathione obviously, you know, I use liposomal glutathione. Part of the process, the detoxification process that I put together for bio genetics, and the liposomal glutathione is is pretty awesome. The studies on this stuff are, are amazing over IV therapy, you get 100x Cellular uptake. It’s kind of crazy. Okay. But anyway, when you look at the process, you want to think about how do we do the the most for this kid without having a deleterious effect? And glutathione and binders the binders for me are a game changer. small intestinal reabsorb up to 90% of metals that you detox. Think of that’s like, if you mowed your lawn one day, that’d be like you have to go mow 90% of it the next day again. Like you would never stand for that right? But in detoxification you reabsorb 90% of what you spent all day detoxing, you it’s that is why we end up with massive kidney issues and people with heavy metals so it’s just constantly making the kidneys try to filter you know or expose them to these these chemicals over and over. Right so efficiency in detoxification is what you want to figure out. So those two are key. And the detoxification protocol that I put together for him was based off of something that we call the metabolic clearing kit at bio genetics. There’s a deluxe kit which comes with a bunch of liposomal antioxidants. That we use specifically for this type of issue. And the other thing that I had the kid do is get sauna at home. Right and you know, do his best to sit in a sauna 35 to 40 minutes a day 155 degrees and just see if we can start pushing if not some of the the metal the contrast dye that was in there. The the other issues that his body is dealing with the other toxicity issues so that we have some energy to spend on detoxing the metal. So, so that’s pretty cool. So we’re going to run another test on this kid coming up probably in 60 days and and see what we’re looking at.
Bill Clearfield 1:26:11
Okay. Well, thank you. Um, um, this was terrific. And please come back anytime.
1:26:20
Thank you for having me. I appreciate you. Thank
Bill Clearfield 1:26:21
you. It sounds like that your team is more than just you and one or two people in the background there how it helped me to help it uh,
1:26:31
so by genetics is oh man. We’re less than 20 As far as the office staff and all that kind of stuff I don’t know. How many employees they have. But I consult the biogenetics I don’t own biogenetics I just consulted them. And so they’re a good team though. And I appreciate their customer service, which is one of the reasons why I agreed to work with them. So they’re pretty great.
Bill Clearfield 1:26:59
Next question, you know, someone who does presentations quite often it takes me a long time to, you know, get my materials together and all How do you do it? How do you every every week you have something new, you know, okay, this week, this month, we’re going to do for four hours on menopause next month. We’re going to do you know, four hours on on, you know, the the genetics of bad health and how do you do it?
1:27:25
So, number one, I’m just curious. There’s a lot of stuff I don’t know. And so you find something you don’t know and you go down that rabbit hole and and that curiosity is interesting. The other thing is always want to find out what does it mean? Right? There’s tons of providers that know a lot of information, and a lot of researchers that are terrible at putting presentations together because they don’t know how to major in the majors and minor in the minors. Right. So if you if you want to figure out your niche is this okay, this is it. Nobody’s ever asked me this before, so I’m going to give you the secret. The secret is is this, most researchers have no idea how to talk to another human being. And so I read their research and I put it in the terms that people can understand. So it means something, that’s all.
Bill Clearfield 1:28:20
That’s great. That’s it. Yeah, it’s great. So I can’t thank you enough. And Kim has been great. You know, we were supposed to do this a couple of months ago and something happened. I don’t know if you had a family issue or some something happened. But, but so please, you know, please if you don’t mind, we would love to have you at least on our mailing list to keep this great. And please come back. I mean, you you are a unbelievable font of knowledge. And you know, a lot of our group or we started out as hardcore medical doctors and then saw the light so some of us comes to it a little bit late. You can tell by my hair that it’s you know, this is silver and I gray but we’ve we you know, we’ve gone over to the dark side. And and i i You know, I can’t thank you enough and if you look at the chat, you’ll see great talk, you know, up and down the line from our speakers. One question does Chinese parsley slowly reabsorption of detox materials?
1:29:23
Can? It can Yes. So that’s right. And I like to use usually clay and aloe based binders and so the clay and aloe based stuff are it’s it’s pretty good. It’s pretty good. So there’s a gentleman by the name of Dr. Chris shade, if you’re familiar with him, and he’s the gentleman that we had customize our binder product. He’s an you ever want an interesting guest he is in? He’s a riot right?
Bill Clearfield 1:30:00
I will be I will be on I will be on on on the text message with Kim later to get his contact.
1:30:05
Yeah, if she doesn’t have it, just tell her to ask me and I’ll get you guys connected okay. So he’s the world’s foremost authority in my opinion on heavy metal detoxification and he is an entertaining individual. So watch.
Bill Clearfield 1:30:24
And one further comment and don’t take this the wrong way, but I rather like the Steve Jobs. Elizabeth Holmes Well, I will tell you, it gives you you know, that kind of humbled, humbled look that genius looks.
1:30:42
Well, I’m in Minnesota today and it temperature was just plummeting. Say no more. So, thank you for having me. I appreciate you.
Bill Clearfield 1:30:52
Thank you. So much. Anybody else have any other comments questions? Again, if you look in the chat, we have a new website for our conference. And it’s I’ve been we will be sending out information we’re about two months out. And we’ve we will be getting ama CME credits and AOA CME credits. And so, you know, no excuses for it for the MDS in the crowd. Like I said, we have a superstar lineup. If anybody who knows anything about anti aging medicine knows know some of these names, you would pay $2,500 for three days at a forum to see these folks. Some of them get $5,000 for an hour’s talk, and we have a more so it’s a little bit more expensive than we’re used to. But and it’s but we’re in Las Vegas. We’re right on right on the Strip. We have some as you know, those of you have been with us before, you know that we have some pretty nice entertainment. You know, we’ve done Sinatra type cocktail parties, we’ve done murder mystery dinners, you may want to come back to watch.
1:32:02
Hey, I’ll be in for that. That’s fun. Okay.
Bill Clearfield 1:32:05
We have a good time. We have we have some interesting vendors coming. We actually have some compounding pharmacies will be with us this time. And I really want you know, to get a nice crowd, it will be online it will be virtual. Somebody asked if it’s going to be on Zoom. Probably not. We have a private company we’re working with anything else. Dr. Watts again, it was was terrific. Terrific. I know I’ve been bugging him to get you on and we’re really glad that you were able to be with us. We are here every Tuesday night at
1:32:40
this time by the way. All right. Well, make sure make sure
Bill Clearfield 1:32:43
to do you can always tune in. To give it give us give us your two cents on whatever the topic is. In fact, next week. We have Dr. Scott Chandler from Provo, Utah. He is a biological dentist and he’s going to talk to us about mercury fillings, infections, auto immunity and chronic disease. So, as you can tell, we sort of have to hold somewhat fast to our auto immune roots, which we do. But much to the chagrin of the AOA, we’re pretty much out there. They have they have to rein us in a little bit. Wait, one more comment here. Okay, you got a thank you from Dr. scenario. And great talk from Dr. Crowley. Dr. Kim, a la says Biogenics has seven employees. I was wondering I was just wondering what uh, you know, it sounds like you have you know, quite an operation going so. Thank you for the presentation that Nortel thank you for Dr. from Dr. Lino. Really, Dr. Watts, we can’t thank you enough. And anybody else have any problems? Questions? I know it’s late it back back East. So we will be back here same time. Same station next week. I said Dr. Chandler, biological dentist, and please register for the conference and send our flyers and our mailings out to your friends. To your to your mailing lists. We really want a big, big showing. And we still have a Peter McCullough is supposed to be coming the week so he’s a little hard to nail down. And so it doesn’t look like we’re going to be able to do CME for him because I can’t get him to sign the papers that are nice. But he’s supposed to be there on Saturday. And, you know, he’s, uh, you know, all over the news, with whatever it is that he does. I don’t want to have a TV so I don’t watch anything so. So again, Dr. Watts, thank you, Kim. I guess that you there. Thank you so much. For everything everybody else. Any problems questions? We will have the the taping this up probably within 24 to 48 hours. And Dr. Watts if you said you would graciously send you send the slide deck up until our webs are where it is where it shows up is for those of you don’t know a Oh srd.org/webinars We have just about every one we’ve been doing this for about a year and a half. So we have quite a bit of of content there. And you can see some of the some of the some of the things that we’ve done in the past. Okay. Okay, everybody, thank you so much. I will we will see you in same time, same station next week. And, again, everybody, thank you so much, and stay well. Okay,
1:35:40
thank you, Doctor.
Bill Clearfield 1:35:41
You’re very quiet today. Dr. Burgess. This guy here down here. John Burgess. He’s Mike kind of writing in manually. Enjoyed it. Thank you. All right, so Okay, goodnight, everybody.